CoChat
Sign Up
Cited by 22

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016

Xu, Yimin, Patel, Dhavalkumar N., Ng, Suet-Leng P., Tan, Siew-Har, Toh, Dorothy, Poh, Jalene, Lim, Adena Theen, Chan, Cheng-Leng, Low, Min-Yong, Koh, Hwee-Ling·2018·Frontiers in Medicine
DOI 10.3389/fmed.2018.00167PMC PMC6006675
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2018.00167

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. Definition
  2. Wardle, 2014, Indirect and non-health risks associated with complementary and alternative medicine use: an integrative review, Eur J Integr Med., 6, 409, 10.1016/j.eujim.2014.01.001 · DOI
  3. Nortier, 2007, For patients taking herbal therapy–lessons from aristolochic acid nephropathy, Nephrol Dial Transplant., 22, 1512, 10.1093/ndt/gfm167 · DOI
  4. Jha, 2010, Herbal medicines and chronic kidney disease, Nephrology, 15, 10, 10.1111/j.1440-1797.2010.01305.x · DOI
  5. Liu, 2016, Research advances on hepatotoxicity of herbal medicines in China, Biomed Res Int., 2016, 7150391, 10.1155/2016/7150391 · DOI
  6. WHO Traditional Medicine Strategy (2014–2023)
  7. Shaw, 2012, Pharmacovigilance of herbal medicine, J Ethnopharmacol, 140, 513, 10.1016/j.jep.2012.01.051 · DOI
  8. Saokaew, 2011, Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008, Drug Saf., 34, 339, 10.2165/11586590-000000000-00000 · DOI
  9. Uppsala Monitoring Centre - Being a Member of the WHO Programme for International Drug Monitoring
  10. Introduction Guide MedDRA Version 14.0
  11. Patel, 2012, Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009, Clin Toxicol., 50, 481, 10.3109/15563650.2012.700402 · DOI
  12. Zhang, 2007, Efficacy and safety evaluation of glucosamine hydrochloride in the treatment of osteoarthritis, Zhonghua Wai Ke Za Zhi, 45, 998, 10.3760/j.issn:v0529-5815.2007.14.020 · DOI
  13. Villacis, 2006, Do shrimp-allergic individuals tolerate shrimp-derived glucosamine?, Clin Exp Allergy, 36, 1457, 10.1111/j.1365-2222.2006.02590.x · DOI
  14. Woo, 2011, Not all shellfish “allergy” is allergy!, Clin Transl Allergy, 1, 3, 10.1186/2045-7022-1-3 · DOI
  15. Butawan, 2017, Methylsulfonylmethane: applications and safety of a novel dietary supplement, Nutrients, 9, 290, 10.3390/nu9030290 · DOI
  16. Amer, 2013, Possible adverse effects of once-daily oral therapeutic dose of either glucosamine sulfate or glucosamine/chondroitin sulfate on blood cells count in rats, Int Res J Pharm., 4, 24, 10.7897/2230-8407.041007 · DOI
  17. Satghare, 2016, Prevalence and correlates of pain in people aged 60 years and above in Singapore: results from the WiSE study, Pain Res Manag., 2016, 1, 10.1155/2016/7852397 · DOI
  18. Jose, 2006, Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital, Pharmacol Res, 54, 226, 10.1016/j.phrs.2006.05.003 · DOI
  19. Ahmed, 2014, Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study, PLoS ONE, 9, e112133, 10.1371/journal.pone.0112133 · DOI
  20. Budnitz, 2007, Medication use leading to emergency department visits for adverse drug events in older adults, Ann Intern Med, 147, 755, 10.7326/0003-4819-147-11-200712040-00006 · DOI
  21. Klotz, 2009, Pharmacokinetics and drug metabolism in the elderly, Drug Metab Rev., 41, 67, 10.1080/03602530902722679 · DOI · Paper page
  22. Montastruc, 2002, Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France, Fundam Clin Pharmacol., 16, 343, 10.1046/j.1472-8206.2002.00100.x · DOI
  23. Zopf, 2008, Women encounter ADRs more often than do men, Eur J Clin Pharmacol., 64, 999, 10.1007/s00228-008-0494-6 · DOI
  24. Zopf, 2009, Gender-based differences in drug prescription: relation to adverse drug reactions, Pharmacology, 84, 333, 10.1159/000248311 · DOI
  25. Bishop, 2010, Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use, Evid Based Complement Alternat Med., 7, 11, 10.1093/ecam/nen023 · DOI
  26. Chung, 2012, Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies, Health Expect., 17, 622, 10.1111/j.1369-7625.2012.00794.x. · DOI
  27. Sibbritt, 2012, Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older, PLoS ONE, 7, e41540, 10.1371/journal.pone.0041540 · DOI
  28. Nakua, 2015, Gender disparities of chronic musculoskeletal disorder burden in the elderly Ghanaian population: study on global ageing and adult health (SAGE WAVE 1), BMC Musculoskelet Disord., 16, 204, 10.1186/s12891-015-0666-3 · DOI
  29. Alomar, 2014, Factors affecting the development of adverse drug reactions (Review article), Saudi Pharm J., 22, 83, 10.1016/j.jsps.2013.02.003 · DOI
  30. Waxman, 2009, Sex differences in the expression of hepatic drug metabolizing enzymes, Mol Pharmacol., 76, 215, 10.1124/mol.109.056705 · DOI · Paper page
  31. Rodenburg, 2012, Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions, Br J Clin Pharmacol., 74, 1045, 10.1111/j.1365-2125.2012.04310.x · DOI
  32. Franconi, 2014, Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women, Br J Pharmacol., 171, 580, 10.1111/bph.12362 · DOI
  33. Kristoffersen, 2014, Gender differences in prevalence and associations for use of CAM in a large population study, BMC Complement Altern Med., 14, 463, 10.1186/1472-6882-14-463 · DOI
  34. Blumenthal, 2000, Herbal Medicine
  35. Cybulska-Heinrich, 2012, Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma, Mol Vis, 18, 390
  36. Sun, 2013, Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease, Transl Neurodegener, 2, 6, 10.1186/2047-9158-2-6 · DOI
  37. Metz, 2009, Case report of vasculitic rash induced by Ginkgo biloba and/or Horny Goat Weed, Br Med J., 2009, bcr07.2008.0399, 10.1136/bcr.07.2008.0399 · DOI
  38. Roland, 2012, Ginkgo biloba–effect, adverse events and drug interaction, Tidsskr Nor Laegeforen, 132, 956, 10.4045/tidsskr.11.0780 · DOI
  39. Kim, 2015, Analysis of herbal-drug-associated adverse drug reactions using data from spontaneous reporting system in electronic medical records, J Korean Orient Med., 36, 45, 10.13048/jkm.15005 · DOI
  40. Svedlund, 2017, Spontaneously reported adverse reactions for herbal medicinal products and natural remedies in Sweden 2007–15: report from the Medical Products Agency, Drug Real World Outcomes, 4, 119, 10.1007/s40801-017-0104-y · DOI
  41. Jacobsson, 2009, Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden, Pharmacoepidemiol Drug Saf., 18, 1039, 10.1002/pds.1818 · DOI
  42. Tabali, 2012, Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs, J Manag Care Pharm., 18, 427, 10.18553/jmcp.2012.18.6.427 · DOI
  43. Teschke, 2014, Traditional Chinese Medicine induced liver injury, J Clin Translat Hepatol., 2, 80, 10.14218/JCTH.2014.00003 · DOI · Paper page
  44. Chalasani, 2014, ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury, Am J Gastroenterol., 109, 950, 10.1038/ajg.2014.131 · DOI · Paper page
  45. Teo, 2016, Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014, BMC Complement Altern Med., 16, 192, 10.1186/s12906-016-1168-z · DOI · Paper page
  46. Suk, 2012, A prospective nationwide study of drug-induced liver injury in Korea, Am J Gastroenterol., 107, 1380, 10.1038/ajg.2012.138 · DOI · Paper page
  47. Ou, 2015, Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital, SpringerPlus, 4, 802, 10.1186/s40064-015-1600-8 · DOI · Paper page
  48. Frenzel, 2016, Herbal hepatotoxicity: clinical characteristics and listing compilation (Review), Int J Mol Sci., 17, 588, 10.3390/ijms17050588 · DOI · Paper page
  49. Fau, 1997, Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes, Gastroenterology, 113, 1334, 10.1053/gast.1997.v113.pm9322529 · DOI
  50. Sheikh, 1997, Chaparral-associated hepatotoxicity, Arch Intern Med., 157, 913, 10.1001/archinte.1997.00440290099011 · DOI
  51. Tarantino, 2009, Drug-induced liver injury due to “natural products” used for weight loss: a case report, World J Gastroenterol., 15, 2414, 10.3748/wjg.15.2414 · DOI
  52. Navarro, 2013, Catechins in dietary supplements and hepatotoxicity, Dig Dis Sci., 58, 2682, 10.1007/s10620-013-2687-9 · DOI
  53. Patel, 2013, Green tea extract: a potential cause of acute liver failure, World J Gastroenterol., 19, 5174, 10.3748/wjg.v19.i31.5174 · DOI
  54. Galati, 2006, Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins, Free Radic Bio Med, 40, 570, 10.1016/j.freeradbiomed.2005.09.014 · DOI
  55. Probst, 2007, Outbreak of an acute aflatoxicosis in Kenya in 2004: identification of the causal agent, Appl Environ Microbiol., 73, 2762, 10.1128/AEM.02370-06 · DOI
  56. Pawlosky, 2013, Cardiovascular risk: are all NSAIDs alike?, Can Pharm J, 146, 80, 10.1177/1715163513481569 · DOI
  57. Ericson-Neilsen, 2014, Steroids: pharmacology, complications, and practice delivery issues, Ochsner J., 14, 203
  58. Chong, 2015, Corticosteroid adulteration in proprietary Chinese medicines: a recurring problem, Hong Kong Med J, 21, 411, 10.12809/hkmj154542 · DOI
  59. Mathon, 2014, Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry, Food Addit Contam Part A Chem Anal Control Expo Risk Assess., 31, 15, 10.1080/19440049.2013.861934 · DOI
  60. Mans, 2013, Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-Desisobutyl-11-benzylsibutramine, J Pharm Biomed Anal., 83, 122, 10.1016/j.jpba.2013.02.031 · DOI
  61. Hunsel, 2015, A ‘natural’ weight loss product containing sibutramine, Drug Test Anal., 8, 311, 10.1002/dta.1925 · DOI
  62. Patel, 2014, Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges, J Pharm Biomed Anal., 87, 176, 10.1016/j.jpba.2013.04.03 · DOI
  63. Venhuis, 2012, Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks, J Pharm Biomed Anal., 69, 196, 10.1016/j.jpba.2012.02.014 · DOI
  64. Xu, 2016, Isolation and characterization of a tadalafil analogue, N-cyclopentyl nortadalafil in health supplement, J Pharm Biomed Anal., 118, 235, 10.1016/j.jpba.2015.08.005 · DOI
  65. Kee, 2017, Isolation and characterization of a novel dithio-carbodenafil analogue from a health supplement, J Pharm Biomed Anal., 137, 132, 10.1016/j.jpba.2017.01.010 · DOI
  66. Sarma, 2016, Dietary supplements quality analysis tools from the United States Pharmacopeia, Drug Test Anal., 8, 418, 10.1002/dta.1940 · DOI
  67. Boullata, 2005, Natural health product interactions with medication, Nutr Clin Pract., 20, 33, 10.1177/011542650502000133 · DOI
  68. Ge, 2014, Updates on the clinical evidenced herb-warfarin interactions, Evid Based Complement Alternat Med., 2014, 957362, 10.1155/2014/957362 · DOI
  69. Lim, 2005, Complementary and alternative medicine use in multiracial Singapore, Complement Ther Med., 13, 16, 10.1016/j.ctim.2004.11.002 · DOI
  70. Grant, 2012, The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review, BMC Public Health, 12, 299, 10.1186/1471-2458-12-299 · DOI
  71. Chen, 2016, Complementary and alternative medicines use among pediatric patients with epilepsy in a multiethnic community, Epilepsy Behav., 60, 68, 10.1016/j.yebeh.2016.04.008 · DOI
  72. Shih, 2009, Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients, Ann Oncol., 20, 752, 10.1093/annonc/mdn659 · DOI
  73. Moon, 2012, Arsenic exposure and cardiovascular disease: an updated systematic review, Curr Atheroscler Rep, 14, 542, 10.1007/s11883-012-0280- · DOI
  74. Genchi, 2017, Mercury exposure and heart diseases, Int J Environ Res Public Health, 14, 74, 10.3390/ijerph14010074 · DOI
  75. Singh, 2011, Mechanisms pertaining to arsenic toxicity, Toxicol Int, 18, 87, 10.4103/0971-6580.84258 · DOI
  76. Tchounwou, 2012, Heavy metals toxicity and the environment, EXS, 101, 133, 10.1007/978-3-7643-8340-4 · DOI
  77. Bernhoft, 2013, Cadmium toxicity and treatment, Sci World J., 2013, 394652, 10.1155/2013/394652 · DOI
  78. Gaetke, 2014, Copper: toxicological relevance and mechanisms, Arch Toxicol., 88, 1929, 10.1007/s00204-014-1355-y · DOI
  79. Barnes, 2003, Pharmacovigilance of herbal medicines: a UK perspective, Drug Saf., 26, 829, 10.2165/00002018-200326120-00001 · DOI
  80. Hazell, 2006, Under-reporting of adverse drug reactions: a systematic review, Drug Saf., 29, 385, 10.2165/00002018-200629050-00003 · DOI

Cited by

Sorted by citations

See all 22

Metadata

Authors
Xu, Y., Patel, D. N., Ng, S.-L. P., Tan, S.-H., Toh, D., Poh, J., Lim, A. T., Chan, C.-L., Low, M.-Y., & Koh, H.-L.
Venue
Frontiers in Medicine
Publisher
Frontiers Media SA
Published
2018-06-12
Volume
5
ISSN
2296-858X
DOI
10.3389/fmed.2018.00167
PMC
PMC6006675
Cited by
22
References
3
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review